By Lisa Kerner
Charlotte, N.C., Nov. 1 - Pathway Medical Technologies, Inc. closed a $25 million round of series B financing.
New investor HLM Venture Partners led the round, joined by Latterell Venture Partners, also a new investor, and existing investors ABN Amro Capital Lifesciences, Giza Ventures and Oxford Bioscience.
"We see this investment as a way to participate in an exciting market with a differentiated and compelling technology," HLM general partner Dan Galles said in a news release.
"In early clinicals, the Pathway Atherectomy System has shown great promise as an effective way to treat patients suffering from peripheral arterial disease."
Pathway Medical is a medical device company located in Redmond, Wash.
| Issuer: | Pathway Medical Technologies, Inc.
|
| Issue: | Series B financing
|
| Amount: | $25 million
|
| Investors: | HLM Venture Partners (lead), Latterell Venture Partners, ABN Amro Capital Lifesciences, Giza Ventures, Oxford Bioscience
|
| Announcement date: | Nov. 1
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
